TP53 and melanoma: For these studies, two melanoma cell lines with varying mutational status of BRAF and TP53 were utilized: A375 (BRAF V600E mutant, TP53 WT), and CHL-1 (BRAF wild type, TP53 homozygous mutant; H193R).